Učitavanje...
Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
Current therapies for acute myeloid leukemia are associated with high failure and relapse rates. Adoptive immunotherapies, which have shown promise in the treatment of hematologic malignancies, have the potential to target acute myeloid leukemia through pathways that are distinct and complementary t...
Spremljeno u:
| Izdano u: | Haematologica |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349272/ https://ncbi.nlm.nih.gov/pubmed/25480499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112748 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|